The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)

dc.contributor.authorInchakalody, Varghese P
dc.contributor.authorHydrose, Shereena P
dc.contributor.authorKrishnankutty, Roopesh
dc.contributor.authorMerhi, Maysaloun
dc.contributor.authorTherachiyil, Lubna
dc.contributor.authorNair, Varun Sasidharan
dc.contributor.authorElashi, Asma A
dc.contributor.authorKhan, Abdul Q
dc.contributor.authorTaleb, Sara
dc.contributor.authorRaza, Afsheen
dc.contributor.authorETAL..
dc.date.accessioned2023-03-15T06:19:43Z
dc.date.accessioned2023-08-19T08:47:33Z
dc.date.available2023-03-15T06:19:43Z
dc.date.available2023-08-19T08:47:33Z
dc.date.issued2023-02
dc.description.abstractDysregulated epigenetic modifications are common in lung cancer but have been reversed using demethylating agent like 5-Aza-CdR. 5-Aza-CdR induces/upregulates the NY-ESO-1 antigen in lung cancer. Therefore, we investigated the molecular mechanisms accompanied with the epigenetic regulation of NY-ESO-1 in 5-Aza-CdR-treated NCI–H1975 cell line. We showed significant induction of the NY-ESO-1 protein (**p < 0.0097) using Cellular ELISA. Bisulfite-sequencing demonstrated 45.6% demethylation efficiency at the NY-ESO-1 gene promoter region and RT-qPCR analysis confirmed the significant induction of NY-ESO-1 at mRNA level (128-fold increase, *p < 0.050). We then investigated the mechanism by which 5-Aza-CdR inhibits cell proliferation in the NCI–H1975 cell line. Upregulation of the death receptors TRAIL (2.04-fold *p < 0.011) and FAS (2.1-fold *p < 0.011) indicate activation of the extrinsic apoptotic pathway. The upregulation of Voltage-dependent anion-selective channel protein 1 (1.9-fold), Major vault protein (1.8-fold), Bax (1.16-fold), and Cytochrome C (1.39-fold) indicate the activation of the intrinsic pathway. We also observed the differential expression of protein Complement C3 (3.3-fold), Destrin (−5.1-fold), Vimentin (−1.7-fold), Peroxiredoxin 4 (−1.6-fold), Fascin (−1.8-fold), Heme oxygenase-2 (−0.67-fold**p < 0.0055), Hsp27 (−0.57-fold**p < 0.004), and Hsp70 (−0.39-fold **p < 0.001), indicating reduced cell growth, cell migration, and metastasis. The upregulation of 40S ribosomal protein S9 (3-fold), 40S ribosomal protein S15 (4.2-fold), 40S ribosomal protein S18 (2.5-fold), and 60S ribosomal protein L22 (4.4-fold) implied the induction of translation machinery. These results reiterate the decisive role of 5-Aza-CdR in lung cancer treatment since it induces the epigenetic regulation of NY-ESO-1 antigen, inhibits cell proliferation, increases apoptosis, and decreasesen_US
dc.identifier.citationInchakalody, V. P., Hydrose, S. P., Krishnankutty, R., Merhi, M., Therachiyil, L., Nair, V. S., ... & Dermime, S. (2023). The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR). European Journal of Pharmacology, 175612.en_US
dc.identifier.doihttps://doi.org/10.1016/j.ejphar.2023.175612
dc.identifier.urihttps://edms.wexl.in/handle/1/4392
dc.language.isoenen_US
dc.publisherELSEVIERen_US
dc.subjectNon small lung canceren_US
dc.subject5 Aza-CdRen_US
dc.subjectEpigenetic regulationen_US
dc.subjectNY-ESO-1en_US
dc.subjectApoptosisen_US
dc.subjectIntrinsic and extrinsic apoptotic pathwayen_US
dc.titleThe molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)en_US
dc.title.alternativeJournal articleen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The molecular mechanisms of apoptosis.pdf
Size:
6.26 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:

Collections